FIELD: medicine. SUBSTANCE: method involves the use of immunomodulating agents at low titer of blood specific antibodies based on belong of antibodies to classes of immunoglobulins at subacute, obliterated, unapparent, slow or chronic infection course which are given every day or each other day. These agents are combined with oral and/or rectal administration of bifidumbacterin preparations and/or acylact. Then after elevation of blood antibody titer and based on belong of antibodies to classes of immunoglobulins antibiotic therapy is prescribed for 5-14 days. At the end of treatment immunomodulating agents are used again in combination with oral and/or rectal administration of bifidumbacterin and/or acylact administration. Suppositories containing recombinant α2-interferon and immunoglobulins at effective amount, suppositories or suspension with bifidumbacterin and suppositories or suspension with acylact are administrated successively for 5-10 days in infections of female genital organs by intravaginal route. Method ensures to achieve the recovery of patients with sluggish infections using sparing immunocorrection ways. EFFECT: improved method of treatment. 3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
FOOD BIOLOGICALLY ACTIVE ADDITION | 1999 |
|
RU2144294C1 |
METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 1999 |
|
RU2144832C1 |
METHOD FOR ASSESSING MUCOSAL IMMUNITY STATE OF OPEN CAVITIES OF DIFFERENT LOCALISATION ACCOMPANYING PREDICTION OF CLINICAL COURSE OF INFECTIOUS-INFLAMMATORY PROCESSES, AND METHOD FOR CORRECTING INFECTIOUS-INFLAMMATORY PROCESSES | 2014 |
|
RU2556958C1 |
METHOD OF TRICHOMONIASIS TREATMENT | 1997 |
|
RU2114634C1 |
IMMUNOBIOLOGICAL ANTIALLERGIC AGENT (VERSIONS) AND LACTOBACILLUS ACIDOPHILUS STRAIN USED FOR PRODUCTION OF IMMUNOBIOLOGICAL ANTIALLERGIC AGENT | 2009 |
|
RU2460781C2 |
BIOLOGICALLY ACTIVE FOOD ADDITION | 1998 |
|
RU2125389C1 |
BIOLOGICALLY ACTIVE ADDITION | 2000 |
|
RU2164765C1 |
METHOD OF PREPARING IMMUNOGLOBULIN PREPARATION CONTAINING RECOMBINANT ALPHA-2-INTERFERON | 1997 |
|
RU2116083C1 |
COMPOSITION ELICITING ANTIVIRAL EFFECT | 2004 |
|
RU2247576C1 |
Authors
Dates
2000-03-20—Published
1999-05-17—Filed